Prostate Cancer - Results from #24280

Guideline-discordant androgen deprivation therapy in localized prostate cancer: Patterns of use in the medicare population and cost implications - Abstract January 25, 2013

Interaction of adjuvant androgen deprivation therapy with patient comorbidity status on overall survival after radical prostatectomy for high-risk prostate cancer - Abstract January 25, 2013

Results from the Scandinavian Prostate Cancer Group Trial Number 4: A randomized controlled trial of radical prostatectomy versus watchful waiting - Abstract January 25, 2013

Effect of leuprolide on serum amyloid-β peptide levels and memory in patients with prostate cancer with biochemical recurrence - Abstract January 25, 2013

Use of immunohistochemistry in routine workup of prostate needle biopsies - Abstract January 25, 2013

Real-time sonoelastography compared to magnetic resonance imaging using four different modalities at 3.0T in the detection of prostate cancer: Strength and weaknesses - Abstract January 25, 2013

Patients with metabolic syndrome and widespread high grade prostatic intraepithelial neoplasia are at a higher risk factor of prostate cancer on re-biopsy: A prospective single cohort study - Abstract January 25, 2013

Personal epigentic "signatures" found consistent in prostate cancer patient metastases January 24, 2013

What is the risk posed by prostate cancer? - Abstract January 24, 2013

Active surveillance for prostate cancer: An underutilized opportunity for reducing harm - Abstract January 24, 2013

Overview of randomized controlled treatment trials for clinically localized prostate cancer: Implications for active surveillance and the United States Preventative Task Force report on screening - Abstract January 24, 2013

Temporal changes in the pathologic assessment of prostate cancer - Abstract January 24, 2013

Temporal changes in the clinical approach to diagnosing prostate cancer - Abstract January 24, 2013

The Prostate Cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): Design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically Loca January 24, 2013

Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer - Abstract January 24, 2013

Contemporary methods of treatment in local advanced prostate cancer - Abstract January 24, 2013

Castration resistant prostate cancer (CRPC): State of the art, perspectives and new challenges - Abstract January 24, 2013

The learning curve of transrectal ultrasound-guided prostate biopsies: Implications for training programs - Abstract January 24, 2013

Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone - Abstract January 24, 2013

2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: A randomised, phase 3 trial - Abstract January 23, 2013

Page 1215 of 1450